Neuropathic Pain Market on Approval and Launch of New Products to Expand

Senzer Pharmaceuticals secured the Investigational New Drug application and data package for its ongoing FDA registration program from its former US strategic partner in order to get approval for its cannabinoid respiratory device for the treatment of side effects induced by anti-cancer treatments, specifically nausea, vomiting, and neuropathic pain.

Neuropathic pain refers to damage or disease of the central nervous system which causes malfunctioning of the pain pathways within the body. The damage can be extensive resulting in necrosis or wasting of muscle, fascia, tendons, and ligaments. Neuromuscular diseases such as diabetes, Parkinson's disease, spinal injuries, and rheumatoid arthritis are among the causes of neuropathic pain. Neuropathic pain can affect any part of the body and can cause unbearable pain, chronic fatigue, muscular weakness, and even immobility. Neuropathic pain can be acute, sub-acute, chronic, or acute neuropathic pain.

Exclusive offer!!! Purchase the report at a discounted rate!!!

Flat Instant discount of US$ 2000

Buy This Complete A Business Report:
https://www.coherentMarketinsights.com/promo/buynow/3656

The growing prevalence of cancer is propelling the growth of the global neuropathic pain market. For instance, according to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in 2018. Also, the increasing geriatric population is again fostering the growth of the market.

For instance, according to the World Health Organization, the geriatric population is expected to reach 2 billion by 2050, up from 900 million in 2015. Additionally, the growing prevalence of neuropathic-like pain in psoriatic arthritis is expected to support the growth of the market. For example, in July 2019, researchers from Cardiff University, U.K., reported that neuropathic-like pain as evidence of abnormal pain processing is common in patients with psoriatic arthritis.

Furthermore, an increase in R&D in neuropathic pain treatment is further projected to augment the growth of the neuropathic pain market. For instance, in March 2020, researchers from Heidelberg University, Germany, reported an assessment of the phytochemical composition and the possible prophylactic effects of an aqueous ethanol extract of Haematoxylon campechianum flowers on peripheral neuropathic pain in a chronic constriction injury rat model.

In April 2019, Daiichi Sankyo Company, Limited announced the launch of Tarlige® Tablets 2.5 mg, 5 mg, 10 mg, 15 mg (generic name: mirogabalin besilate; hereafter, the drug) for the treatment of pain in Japan

In July 2019, Drug major Cipla announced its subsidiary InvaGen Pharmaceuticals has received final approval from the US health regulator for Pregabalin Capsules, indicated for the management of neuropathic pain associated with certain illnesses

For Customization on this Report @ https://www.coherentmarketinsights.com/insight/request-customization/3656

Major Market Competitors: Pfizer, Inc., Johnson & Johnson Services, Inc., Sanofi S.A., Eily Lily and Company, GlaxoSmithKline PLC, Biogen Idec., Bristol-Myers Squibb, Baxter Healthcare Corporation, and Depomed, Inc.

Market Segmentation

By Drug Class:

Tricyclic Anti-Depressant
Anticonvulsant
Local Anaesthesia
Opioids
Steroids
Others
By Indication:

Diabetic neuropathy
Chemotherapy-induced Peripheral neuropathy
Other
By Distribution Channel:

Retail Pharmacies
Drug Store
Online Pharmacies

Download PDF Sample Report @
https://www.coherentmarketinsights.com/insight/request-sample/3656
Covid-19 Impact:

The COVID-19 pandemic has exacerbated the world’s healthcare challenges. Social distancing and shutdowns have accelerated adoption of digital technologies in the healthcare sector. Our updated reports have answers to various concerns in the global Neuropathic Pain market caused due to the pandemic.

Contact us:
Mr. Shah
Senior Client Partner – Business Development
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
sales@coherentMarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.